Lebray P - Search Results

1

Pol S, Vallet-Pichard A, Fontaine H, Lebray P. Pol S, et al. Among authors: lebray p. Semin Nephrol. 2002 Jul;22(4):331-9. Semin Nephrol. 2002. PMID: 12118398 Review.

2

Clinical and genetic definition of serum bilirubin levels for the diagnosis of Gilbert syndrome and hypobilirubinemia.

Poynard T, Deckmyn O, Peta V, Sakka M, Lebray P, Moussalli J, Pais R, Housset C, Ratziu V, Pasmant E, Thabut D; FibroFrance Group. Poynard T, et al. Among authors: lebray p. Hepatol Commun. 2023 Sep 22;7(10):e0245. doi: 10.1097/HC9.0000000000000245. eCollection 2023 Oct 1. Hepatol Commun. 2023. PMID: 37738404 Free PMC article.

3

NNRTI-related or -unrelated hepatotoxicity?

Lebray P, Benhamou Y, Pol S, Myers RP, Poynard T, Di Martino V. Lebray P, et al. Hepatology. 2002 Aug;36(2):512-3; author reply 513-4. doi: 10.1053/jhep.2002.34295. Hepatology. 2002. PMID: 12143068 No abstract available.

4

N-acetylcysteine for paracetamol poisoning: effect on prothrombin.

Pol S, Lebray P. Pol S, et al. Among authors: lebray p. Lancet. 2002 Oct 12;360(9340):1115. doi: 10.1016/S0140-6736(02)11238-4. Lancet. 2002. PMID: 12387954 No abstract available.

5

Immunomodulatory drugs and therapeutic vaccine in chronic hepatitis B infection.

Lebray P, Vallet-Pichard A, Michel ML, Fontaine H, Sobesky R, Bréchot C, Pol S. Lebray P, et al. J Hepatol. 2003;39 Suppl 1:S151-9. doi: 10.1016/s0168-8278(03)00336-2. J Hepatol. 2003. PMID: 14708695 Review. No abstract available.

6

HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms.

Pol S, Lebray P, Vallet-Pichard A. Pol S, et al. Among authors: lebray p. Clin Infect Dis. 2004 Mar 1;38 Suppl 2:S65-72. doi: 10.1086/381499. Clin Infect Dis. 2004. PMID: 14986277

7

Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C.

Lebray P, Zylberberg H, Hue S, Poulet B, Carnot F, Martin S, Chretien Y, Pol S, Caillat-Zuckman S, Bréchot C, Nalpas B. Lebray P, et al. J Viral Hepat. 2004 Mar;11(2):175-82. doi: 10.1046/j.1365-2893.2003.00488.x. J Viral Hepat. 2004. PMID: 14996353

8

Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C.

Fontaine H, Vallet-Pichard A, Equi-Andrade C, Nalpas B, Verkarre V, Chaix ML, Lebray P, Sobesky R, Serpaggi J, Kreis H, Pol S. Fontaine H, et al. Among authors: lebray p. Transplantation. 2004 Sep 27;78(6):853-7. doi: 10.1097/01.tp.0000128911.87538.aa. Transplantation. 2004. PMID: 15385804

9

Prevalence of mixed cryoglobulins in relation to CD4 cell count among patients coinfected with HIV and hepatitis C virus.

Aaron L, Lebray P, Alyanakian MA, Roudière L, Therby A, Chaix ML, Dupont B, Pol S, Viard JP. Aaron L, et al. Among authors: lebray p. Clin Infect Dis. 2005 Jan 15;40(2):306-8. doi: 10.1086/427029. Epub 2004 Dec 20. Clin Infect Dis. 2005. PMID: 15655752

10

The impact of haematopoietic growth factors on the management and efficacy of antiviral treatment in patients with hepatitis C virus.

Lebray P, Nalpas B, Vallet-Pichard A, Broissand C, Sobesky R, Serpaggi J, Fontaine H, Pol S. Lebray P, et al. Antivir Ther. 2005;10(6):769-76. Antivir Ther. 2005. PMID: 16218177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

109 results

Search Page

Filters